Lichtenberg, Frank; Waldfogel, Joel - National Bureau of Economic Research (NBER) - 2003
With substantial fixed costs of drug development, more common conditions can support more products. If additional pharmaceutical products are beneficial, they will attract greater consumption and promote better health, e.g. greater longevity. We ask how market size measured by condition...